Archive for February 2023
Exclusive: Tufts researchers’ limb-regeneration startup raises funding
Human limb and organ regeneration seems like the stuff of science fiction. But in the labs of Tufts University professors Michael Levin and David Kaplan, it’s becoming a reality. Read More
Read MoreFive things you need to know, and who’s bleeding (red ink)
Here are the five things you need to know in Boston business news to start your workday, and how our local hospitals are responding to financial headwinds. Read More
Read MoreBoston Children’s taps Wendy Chung as new pediatrics chief
Dr. Wendy Chung comes to Boston from Columbia University Irving Medical Center/NewYork-Presbyterian Morgan Stanley Children’s Hospital. Read More
Read MoreAs Head Start faces a workforce crisis, state leaders noncommittal on funding increase
Massachusetts legislative leaders offered support, but not necessarily the $1 million funding increase, sought by Head Start programs during a lobbying day held by the organization at the State House Tuesday. Read More
Read MoreThe Playbook: These issues could cause headaches for employers in 2023
In this edition of The Playbook, we take a look at the pros and cons of using ChatGPT for business, why hiring managers still need to move fast and the under-the-radar issues that could trip up employers. Read More
Read MoreVicarious Surgical’s shares pop following 14% workforce reduction
Vicarious Surgical Inc. is laying off employees as part of a series of steps to extend its cash runway. Read More
Read MoreBain buys $50M stake in newly public blood disorder company Disc Medicine
When the sale wraps up on Wednesday, Bain will be Disc’s largest institutional shareholder, based on a review of publicly available filings. The Boston-based investment firm contributed $50 million to the consortium through its life sciences arm. Read More
Read MoreSesen Bio, Carisma Therapeutics amend merger deal after reaching agreement with investor group
A Sesen Bio investor group last month proposed an alternative to the Cambridge biotech’s planned merger with Carisma that it said would deliver "superior value" for the company’s stockholders. Now the group is on board with the deal. Read More
Read MoreSoftware firm brings back founding CEO after less than one year
Globalization Partners, or G-P, had about 80 workers based in Greater Boston last year. Read More
Read MoreHealth Policy Commission will emphasize ‘increased diversity and perspectives’ with new appointees
The Health Policy Commission recently announced 10 new members of its advisory council, with an "emphasis on increased diversity and perspectives." Read More
Read More